FORWARD BIOLABS INC
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$2,631,783
Cash & Equivalents
76%
Property, Plant, & Equipment (net)
14%
Receivables (Non-Related)
8%
Prepaid Expenses
2%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$115,335
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,730,294
$1,990,455
+15%
Receivables (Non-Related)
$209,475
$213,076
+2%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$39,726
$50,722
+28%
Investments
-
-
-
Property, Plant, & Equipment (net)
$457,469
$377,530
-17%
Other Assets
-
-
-
Total Assets
$2,436,964
$2,631,783
+8%
Liabilities
2023
2024
Change
Payables & Accruals
$79,177
$115,335
+46%
Grants Payable
-
-
-
Deferred Revenue
$0
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$79,177
$115,335
+46%
Net assets
2023
2024
Change
Restricted Net Assets
$146,100
$151,410
+4%
Unrestricted Net Assets
$2,211,687
$2,365,038
+7%
Net assets
2023
2024
Change
Net assets
+$2,357,787
+$2,516,448
+7%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)